115 related articles for article (PubMed ID: 10546933)
1. Circulating antipericyte autoantibodies in diabetic retinopathy.
Attawia MA; Nayak RC
Retina; 1999; 19(5):390-400. PubMed ID: 10546933
[TBL] [Abstract][Full Text] [Related]
2. Circulating anti-pericyte autoantibodies are present in Type 2 diabetic patients and are associated with non-proliferative retinopathy.
Nayak RC; Agardh CD; Kwok MG; Stjernquist H; Farthing-Nayak PJ; Agardh E
Diabetologia; 2003 Apr; 46(4):511-3. PubMed ID: 12739023
[TBL] [Abstract][Full Text] [Related]
3. [The role of anti-pericyte antibodies in the development of diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Klin Oczna; 2005; 107(7-9):541-3. PubMed ID: 16417018
[TBL] [Abstract][Full Text] [Related]
4. Circulating antipericyte autoantibodies: a novel modifier of risk of progression of diabetic retinopathy?
Nayak RC; Lynch K; Gustavsson C; Kwok MG; Farthing-Nayak PJ; Agardh CD; Agardh E
Retina; 2007 Feb; 27(2):211-5. PubMed ID: 17290204
[TBL] [Abstract][Full Text] [Related]
5. Albuminuria and hypertension are independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients.
Nayak RC; Agardh E; Kwok MG; Farthing-Nayak PJ; Lynch K; Agardh CD
Metabolism; 2005 Feb; 54(2):188-93. PubMed ID: 15690312
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy.
Li Y; Smith D; Li Q; Sheibani N; Huang S; Kern T; Nagaraj RH; Lin F
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5520-6. PubMed ID: 22786897
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial cell antibodies in diabetic patients. Association with diabetic retinopathy.
Jones DB; Wallace R; Frier BM
Diabetes Care; 1992 Apr; 15(4):552-5. PubMed ID: 1499477
[TBL] [Abstract][Full Text] [Related]
8. Could diabetic retinopathy be an autoimmune disease?
Kastelan S; Zjacić-Rotkvić V; Kastelan Z
Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
[TBL] [Abstract][Full Text] [Related]
9. Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy.
Vavuli S; Salonurmi T; Loukovaara S; Nissinen AE; Savolainen MJ; Liinamaa MJ
J Diabetes Res; 2016; 2016():2614153. PubMed ID: 28090539
[No Abstract] [Full Text] [Related]
10. Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients.
Zhang L; Li Y; Payne J; Srivastava S; Fan X; Fung J; Li X; Kern TS; Lin F
Sci Rep; 2016 Feb; 6():20341. PubMed ID: 26839120
[TBL] [Abstract][Full Text] [Related]
11. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects.
Mazzeo A; Beltramo E; Lopatina T; Gai C; Trento M; Porta M
Exp Eye Res; 2018 Nov; 176():69-77. PubMed ID: 30008390
[TBL] [Abstract][Full Text] [Related]
12. [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].
Dorchy H; Lemiere B; Toussaint D; Gausset P
Nouv Presse Med; 1981 Sep; 10(34):2795-8. PubMed ID: 7031599
[TBL] [Abstract][Full Text] [Related]
13. Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.
Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Noma H; Amano S; Araie M; Iwamoto Y; Hori S
Diabet Med; 2004 Jun; 21(6):559-62. PubMed ID: 15154939
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
[TBL] [Abstract][Full Text] [Related]
15. Detection of serum antibodies cross-reacting with Mycobacterium avium subspecies paratuberculosis and beta-cell antigen zinc transporter 8 homologous peptides in patients with high-risk proliferative diabetic retinopathy.
Pinna A; Masala S; Blasetti F; Maiore I; Cossu D; Paccagnini D; Mameli G; Sechi LA
PLoS One; 2014; 9(9):e107802. PubMed ID: 25226393
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.
Jaeger C; Hatziagelaki E; Petzoldt R; Bretzel RG
Diabetes Care; 2001 Jan; 24(1):27-32. PubMed ID: 11194235
[TBL] [Abstract][Full Text] [Related]
17. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
[TBL] [Abstract][Full Text] [Related]
18. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.
Gorus FK; Sodoyez JC; Pipeleers DG; Keymeulen B; Foriers A; Van Schravendijk CF
Diabetologia; 1992 Nov; 35(11):1080-6. PubMed ID: 1473619
[TBL] [Abstract][Full Text] [Related]
19. Retinal capillary pericyte apoptosis in early human diabetic retinopathy.
Li W; Yanoff M; Liu X; Ye X
Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318
[TBL] [Abstract][Full Text] [Related]
20. Pericyte mitogenic activity is reduced in the blood of type 1 diabetic patients with and without retinopathy.
Williams FM; Dosso AA; Kohner EM; Porta M
Acta Diabetol; 1993; 30(3):123-7. PubMed ID: 8111070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
